AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23209276
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) treatment (160 mg daily) until the day before CABG
Trial: 23209276
Drug: No ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ASA treatment (withdrawal 7 days before surgery)
Trial: 3328281
Drug: ASA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA treatment
Trial: 21515871
Drug: FES with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FES with intramuscular (IM) electrodes (FES‐IM)
Trial: 9659350
Drug: Inhaled L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled L-arginine 3 g
Trial: 9659350
Drug: Inhaled L-alanine
RxNorm normalized name: L-alanine
DrugBank: Alanine (DB00160)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled L-alanine 3 g
Trial: 766555
Drug: Bromocriptine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (5 mg daily for 14 days)
Trial: 766555
Drug: Diethylstilboestrol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylstilboestrol (20 mg daily for 7 days followed by placebo for 7 days)
Trial: 766555
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (20 women not receiving any medication)
Trial: 24879357
Drug: EPA-DHA (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA-DHA (400 mg/day)
Trial: 24879357
Drug: ALA (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA (2 g/day)
Trial: 21244606
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of tadalafil once daily
Trial: 16505089
Drug: Aprotinin (30,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (30,000 kIU) plus local anaesthetic injection and eccentric exercise
Trial: 16505089
Drug: Saline (0.9%)
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline (0.9%) plus local anaesthetic injections and eccentric exercises
Trial: 11328224
Drug: Crinone 8%
RxNorm normalized name: Crinone 8% Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone 8% Vaginal Gel administered once daily in the morning for luteal phase support.
Trial: 11328224
Drug: Intramuscular progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular progesterone for luteal phase support.
Trial: 16607146
Drug: Successful eradication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Successful eradication therapy
Trial: 9836101
Drug: Unsuccessful eradication
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unsuccessful eradication therapy
Trial: 7926137
Drug: Depot leuprolide
RxNorm normalized name: leuprolide acetate Injectable Suspension [Lupron Depot]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depot leuprolide acetate (GnRH‐a) 7.5 mg with estrogen (0.625 mg/d) and progestin (Medroxyprogesterone acetate 10 mg/d)
Trial: 31829833
Drug: Incisional negative-pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incisional negative-pressure wound therapy (NPWT)
Trial: 31484565
Drug: Low-dose information
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose information program with follow-up email support and resources including an activity tracker (Fitbit) for 3 months and free trial class at the university sports facility
Trial: 21081834
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment (pravastatin 10 mg/day, fluvastatin 20 mg/day, pitavastatin 1 mg/day, atorvastatin 10 mg/day)
Trial: 21081834
Drug: Control (non-statin-treated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (non-statin-treated group with LDL-C < 140 mg/dL)
Trial: 11735093
Drug: Metformin (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850 mg twice daily) for 8 weeks
Trial: 8260300
Drug: Pancuronium (neuromuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium (neuromuscular blocker)
Trial: 8260300
Drug: Alcuronium (neuromuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcuronium (neuromuscular blocker)
Trial: 2888937
Drug: Tranquilizers (diazepam)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tranquilizers (diazepam)
Trial: 29771080
Drug: Systemic corticosteroid
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic corticosteroid monotherapy
Trial: 29771080
Drug: Intratympanic corticosteroid
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic corticosteroid monotherapy
Trial: 29771080
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (IT plus systemic corticosteroid)
Trial: 29771080
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups combined (systemic, IT, and combination therapy)
Trial: 26845463
Drug: 15 patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 patients who shifted from heavy smoking to low-moderate levels post treatment
Trial: 24465955
Drug: 3 glasses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 glasses of sparkling white wine (30 g alcohol)
Trial: 22183172
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg lamivudine (3TC) once daily for 10 days
Trial: 22183172
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg lamivudine (3TC) once daily for 10 days
Trial: 22183172
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg lamivudine-triphosphate (3TC-TP) once daily for 10 days
Trial: 22183172
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg lamivudine-triphosphate (3TC-TP) once daily for 10 days
Trial: 17485597
Drug: Candesartan (Atacand,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (Atacand, Astra Zeneca), 16 mg o.d. for 12 months
Trial: 16110036
Drug: Imatinib (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (initial dose)
Trial: 7657800
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus fat/heparin
Trial: 7657800
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus glycerol
Trial: 7657800
Drug: Saline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline plus fat/heparin
Trial: 7657800
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus fat/heparin (euglycemic)
Trial: 7657800
Drug: Insulin (euglycemic)
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin (euglycemic)
Trial: 779562
Drug: DM-prostaglandin E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DM-prostaglandin E2 capsule (127 mug)
Trial: 779562
Drug: DM-prostaglandin E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DM-prostaglandin E2 capsule
Trial: 31650500
Drug: Conservative oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative oxygen administration (SpO2 target of 90% with FreeO2 device)
Trial: 31650500
Drug: Liberal oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal oxygen administration (SpO2 target of ≥ 95% with manual titration)
Trial: 31650500
Drug: Liberal oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal oxygen administration in retainers
Trial: 31650500
Drug: Liberal oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal oxygen administration in non-retainers
Trial: 30640653
Drug: Single-injection serratus
RxNorm normalized name: Fucus serratus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection serratus block with L-bupivacaine 0.25% 30mL
Trial: 19620065
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus astragalus
Trial: 10569127
Drug: Maintenance placebo,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance placebo, nortriptyline, or combination treatment
Trial: 10096460
Drug: oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral contraceptives
Trial: 29852043
Drug: Trastuzumab for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab for 9 weeks with docetaxel (80 or 100 mg/m2) followed by 3 cycles of fluorouracil, epirubicin, and cyclophosphamide
Trial: 29852043
Drug: Trastuzumab for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab for 1 year with identical chemotherapy
Trial: 24768615
Drug: Levodopa (dopaminergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa (dopaminergic medication)
Trial: 22649263
Drug: Polydextrose (PDX;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polydextrose (PDX; 21 g/d)
Trial: 20181812
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus Vitamin D (1 g elemental Ca as carbonate plus 400 IU vitamin D(3)/d)
Trial: 18614429
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg (Test)
Trial: 18614429
Drug: Ciproxin 500
RxNorm normalized name: Ciproxin 500 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciproxin 500 mg (Reference)
Trial: 11919231
Drug: Early radiotherapy
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early radiotherapy with concurrent chemotherapy (arm I)
Trial: 11919231
Drug: Late radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Late radiotherapy with chemotherapy (arm II)
Trial: 10342082
Drug: Norethindrone acetate
RxNorm normalized name: Norethindrone Acetate
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethindrone acetate (1 mg)/ethinyl estradiol (35 micrograms)
Trial: 10342082
Drug: Norethindrone acetate
RxNorm normalized name: Norethindrone Acetate
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethindrone acetate (1 mg)/ethinyl estradiol (20 micrograms)
Trial: 28448590
Drug: Selenium and
RxNorm normalized name: Selenium and/or selenium compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium and coenzyme Q10 supplementation (200 μg Se/day as organic selenium yeast tablets and 200 mg/day of coenzyme Q10 capsules)
Trial: 19254592
Drug: Oral contraception
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraception (OC)
Trial: 9215516
Drug: Combined antioxidant
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined antioxidant vitamin capsules providing 400 IU/day vitamin E, 500 mg/day vitamin C, and 6 mg/day beta-carotene
Trial: 8267470
Drug: Low-flow bypass
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flow bypass (50 mL · kg‐1 · min‐1)
Trial: 3302061
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ethionamide, rifampicin, or clofazimine with dapsone)
Trial: 3302061
Drug: Dapsone plus
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dapsone plus rifampicin combination
Trial: 7840553
Drug: Dapsone monotherapy
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dapsone monotherapy
Trial: 3302061
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (including dapsone monotherapy)
Trial: 31203378
Drug: Liraglutide (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (0.06 mg)
Trial: 31203378
Drug: Exenatide (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (0.5 μg)
Trial: 31203378
Drug: Liraglutide (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (0.06 mg) with exendin-(9,39) pretreatment
Trial: 25743734
Drug: EASE program
RxNorm normalized name: BOIL-EASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EASE program (3 weeks duration, including a 570-minute group meeting and telephone counseling twice a week)
Trial: 23735098
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy (18 hours/week for 6 months)
Trial: 21705689
Drug: Oral palmitoyl-ethanolamide
RxNorm normalized name: Palmitoyl ethanolamide
DrugBank: Palmidrol (DB14043)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral palmitoyl-ethanolamide (PEA) 300-mg tablets twice a day
Trial: 21705689
Drug: Placebo (PEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PEA vehicle tablets twice a day)
Trial: 8405695
Drug: Acipimox (slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (slow-release formulation)
Trial: 8405695
Drug: Acipimox (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (administered every 2 hours for 4 days)
Trial: 3530849
Drug: Nicardipine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (0.5 mg)
Trial: 30690860
Drug: DBBM +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBBM + L‐PRF (test)
Trial: 28601864
Drug: Higher Protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher Protein Diet (HPD) 1.34 g/kg body weight
Trial: 28601864
Drug: Standard Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Protein Diet (SPD) 0.8 g/kg body weight
Trial: 26661283
Drug: Conventional antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antibiotic treatments
Trial: 26621715
Drug: D-cycloserine (DCS)
RxNorm normalized name: D-Cycloserine
DrugBank: Cycloserine (DB00260)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D-cycloserine (DCS) 100 mg
Trial: 22992332
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (VPA) 400 mg
Trial: 19673649
Drug: Rapid virologic
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid virologic clearance and low-level viremia (HCV RNA level, <400,000 IU/mL)
Trial: 19673649
Drug: Complete viral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete viral suppression after 4 weeks of treatment (RVR)
Trial: 16699278
Drug: Rifaximin-based triple
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifaximin-based triple therapy (rifaximin 400 mg t.i.d., esomeprazole 40 mg o.d., clarithromycin 500 mg b.i.d.)
Trial: 16699278
Drug: Levofloxacin-based therapy
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin-based therapy (levofloxacin 500 mg o.d.)
Trial: 15041399
Drug: EC‐MPS 720
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EC‐MPS 720 mg b.i.d.
Trial: 11458721
Drug: Urapidil (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (25 mg)
Trial: 11458721
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 ml isotonic saline)
Trial: 9916608
Drug: Maalox 30
RxNorm normalized name: Maalox
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox 30 mL given 2 hours before sparfloxacin
Trial: 9916608
Drug: Maalox 30
RxNorm normalized name: Maalox
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox 30 mL given 2 hours after sparfloxacin
Trial: 9916608
Drug: Maalox 30
RxNorm normalized name: Maalox
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox 30 mL given 4 hours after sparfloxacin
Trial: 2914634
Drug: HCl solutions
RxNorm normalized name: Chlorpromazine Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCl solutions (pH 1, 1.5, 2, 2.5, 3, 4, 5, and 6) infused at 8 ml/min
Trial: 26996270
Drug: Higher medication
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher medication adherence self‐efficacy
Trial: 1532445
Drug: Estradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol valerate (2 mg, days 1-21) + Medroxyprogesterone acetate (10 mg, days 12-21)
Trial: 1532445
Drug: 17 beta-estradiol
RxNorm normalized name: 17 beta-estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol (1.5 mg, days 1-24) + Desogestrel (150 micrograms, days 13-24)
Trial: 1532445
Drug: All hormone-treated
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All hormone-treated groups
Trial: 3925217
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) 240 mg daily (6 X 40 mg)
Trial: 30251943
Drug: Intraoperative antithymocyte
RxNorm normalized name: antithymocyte immunoglobulin (rabbit)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative antithymocyte globulin infusion via coronary sinus
Trial: 30251943
Drug: Traditional antithymocyte
RxNorm normalized name: antithymocyte immunoglobulin (rabbit)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional antithymocyte globulin infusion after implantation
Trial: 29111960
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg enteric-coated aspirin daily
Trial: 27368439
Drug: Pranlukast (leukotriene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranlukast (leukotriene antagonist) administered for up to 28 days along with antibiotics.
Trial: 27368439
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received antibiotic-based conventional treatment according to guidelines.
Trial: 24568906
Drug: Huangqi injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Huangqi injection (0.5-1.0 mL/kg per day) by intravenous infusion
Trial: 24568906
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride injection (control)
Trial: 23941474
Drug: Lithium added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium added to current therapy
Trial: 23941474
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy without lithium
Trial: 16174073
Drug: Antiviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiviral therapy (combined interferon (IFN; 3 or 5 million units of IFN alpha‐2b thrice weekly) plus ribavirin (1000‐1200 mg per day) for 24‐48 weeks)
Trial: 8851377
Drug: 10 micrograms.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms.kg‐1 intrathecal morphine (Group A)
Trial: 8851377
Drug: 20 micrograms.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms.kg‐1 intrathecal morphine (Group B)
Trial: 8851377
Drug: 30 micrograms.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 micrograms.kg‐1 intrathecal morphine (Group C)
Trial: 1626757
Drug: Terbutaline Turbuhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline Turbuhaler (0.5 mg qid)
Trial: 1626757
Drug: Albuterol chlorofluorocarbon
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol chlorofluorocarbon (CFC) inhaler (0.2 mg qid)
Trial: 1626757
Drug: Preference for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preference for albuterol CFC inhaler
Trial: 31305232
Drug: Behavioral medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral medicine treatment (BMT)
Trial: 24731671
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg eprotirome
Trial: 24731671
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg eprotirome
Trial: 20491818
Drug: Early implant
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early implant placement (healing sites)
Trial: 20491818
Drug: Conventional implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional implant placement (healed sites)
Trial: 20491818
Drug: Both early
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both early and conventional implant placements